[RDY]

Mid

All available information for this ticker. | View Original

Mid 2026-10-26 00:38:56

Jefferies upgrades Dr. Reddy’s stock rating on margin outlook

Mid 2026-10-24 08:17:08

Dr. Reddy’s outlines semaglutide relaunch in November 2026 and reiterates 6M-7M devices target

Mid 2026-10-24 04:30:24

Dr. Reddy's GAAP EPS of $0.17, revenue of $1.75B

Mid 2026-10-24 00:22:53

Earnings call transcript: Dr. Reddy’s posts modest Q2 2026 beat, stock edges up

Mid 2026-09-18 16:56:51

Dr Reddy’s to distribute Takeda’s dengue vaccine in India

1 / 3